Skip to content
The Policy VaultThe Policy Vault

Pomalyst (pomalidomide)Medica

POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes) syndrome

Initial criteria

  • Patient is ≥ 18 years of age
  • Medication is used in combination with dexamethasone

Approval duration

1 year